Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours

Maja de Jonge; H Dumez; Jaap Verweij; S Yarkoni; D Snyder; D Lacombe; S Marreaud; T Yamaguchi; CJA Punt; A van Oosterom

doi:10.1016/j.ejca.2005.12.027

Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours

Maja de Jonge, H Dumez, Jaap Verweij, S Yarkoni, D Snyder, D Lacombe, S Marreaud, T Yamaguchi, CJA Punt, A van Oosterom

Research output: Contribution to journal › Article › Academic › peer-review

87 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1768-1774
Number of pages	7
Journal	European Journal of Cancer
Volume	42
Issue number	12
DOIs	https://doi.org/10.1016/j.ejca.2005.12.027
Publication status	Published - 2006

Access to Document

10.1016/j.ejca.2005.12.027

http://hdl.handle.net/1765/65092

Cite this

@article{41785c968ca0412ea243ec6b2d584871,

title = "Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours",

author = "{de Jonge}, Maja and H Dumez and Jaap Verweij and S Yarkoni and D Snyder and D Lacombe and S Marreaud and T Yamaguchi and CJA Punt and {van Oosterom}, A",

year = "2006",

doi = "10.1016/j.ejca.2005.12.027",

language = "Undefined/Unknown",

volume = "42",

pages = "1768--1774",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

number = "12",

}

TY - JOUR

T1 - Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours

AU - de Jonge, Maja

AU - Dumez, H

AU - Verweij, Jaap

AU - Yarkoni, S

AU - Snyder, D

AU - Lacombe, D

AU - Marreaud, S

AU - Yamaguchi, T

AU - Punt, CJA

AU - van Oosterom, A

PY - 2006

Y1 - 2006

U2 - 10.1016/j.ejca.2005.12.027

DO - 10.1016/j.ejca.2005.12.027

M3 - Article

SN - 0959-8049

VL - 42

SP - 1768

EP - 1774

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 12

ER -